Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04940013 · ClinicalTrials.gov registry record · Phase 4
Missed Period Pill Study
A Phase 4 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT04940013 is a Phase 4 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 17 participants.
The verdict
NCT04940013, a Phase 4 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The Missed Period Pill Study is a prospective observational study among people who decide to use misoprostol alone for menstrual regulation.
Interventions
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2025-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04940013
The ClinicalTrials.gov registry entry for NCT04940013 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Misoprostol is the first listed.
NCT04940013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04940013 about?
NCT04940013 is a clinical study titled "Missed Period Pill Study". The Missed Period Pill Study is a prospective observational study among people who decide to use misoprostol alone for menstrual regulation.
What is the current status of trial NCT04940013?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2021-10-25. Estimated completion is 2025-09-01.
What interventions are being tested in trial NCT04940013?
The interventions under investigation include: Misoprostol (DRUG).
Who is sponsoring clinical trial NCT04940013?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.